Answers are grounded in this paper and cite their sources.
Cancer cell identity and transitions among states reflect oncogenic mechanisms and predict clinical outcomes. These processes are typically defined through molecular profiling, yet such approaches remain limited in scalability and real-time monitoring. In contrast, nuclear morphology provides a low-dimensional state space that captures cellular identity and dynamic transitions. Using neuroblastoma as a model system, we establish a morphology-based framework that maps individual cells within this state space and tracks their transitions as continuous trajectories. Morphology-defined states show cell line-level concordance with transcriptomic classifications and, at the single-cell level, correspond to molecular and signaling features measured by immunofluorescence. Perturbations targeting Rho-associated kinase signaling and enhancer of zeste homolog 2-mediated epigenetic regulation drive convergent trajectories along a shared phenotypic axis. These results establish nuclear morphology as a state-space representation of neuroblastoma cell identity, providing a practical framework for high-throughput phenotyping and real-time tracking of state transitions.
No takes yet. Share an insight, caveat, or question.
Zamloot et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: